<DOC>
	<DOCNO>NCT01016691</DOCNO>
	<brief_summary>Evaluation ocular safety efficacy drug delivery system open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Safety Efficacy Drug Delivery System Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Man woman 21 year age great Open angle glaucoma ocular hypertension Corrected visual acuity eye 20/200 well Previous glaucoma intraocular surgery refractive surgery Planned contact lens use study Clinically significant ocular systemic disease might interfere study Use chronic corticosteroid route</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>